The analysis of clinical data indicated that the correlation between the expressions of ADAM12 and ESR1 in patients with Luminal A and Luminal B breast cancer was negative; however, the expressions of ADAM12 and ESR2 were not statistically significant. Here, ESR1 is linked to breast cancer.